Articles

Pharma merger and acquisition (M&A) activity soared back to pre-recession levels in 2011 as companies began to feel the heat of the patent cliff, new figures show. International law firm Freshfields Bruckhaus Deringer calculated the value of M&As reached $224 billion (£141 billion) last year, the highest recorded since 2007, when values hit $255 billion. Read more

Signs suggest innovative business development and licensing strategies will continue to move from strength to strength as the industry adjusts to new dynamics and new business models. Read more

When looking at overall spending for 2011 and projected outsourcing spend for 2012, one can determine which customer segments to target based on how the services offered by providers compare to the needs of each segment. Big Pharma showed an increased need for bio-analytical testing, process optimization, stability storage and testing, cytotoxic projects and toxicology. Read more

Patient advocacy groups and organizations are one of the primary backers of research into rare diseases. EURORDIS (Europe) hasmember national alliances in 25 countries. In US, there are several patient advocacy groups, like the Barteks. Read more

According to the International Diabetes Association (IDA), around 26.6 million people in the MENA region had diabetes in 2010, equating to more than one in 20 members of the adult population. Read more

With Pfizer's blockbuster Lipitor set to fall off the patent cliff at the end of November, the generics market is being viewed with a new focus. Read more

Access to expensive medicines is becoming increasingly difficult in Portuguese public hospitals, while savings with retail pharmacy expenditure are expected to be better than projections in the Memorandum of Understanding deal signed by the government. Read more

Work in the British Journal of Sports Medicine suggests a couch potato lifestyle with six hours of TV a day cuts lifespan by five years. Read more

Is it fair to say that providing patients with generics that look different from their branded counterparts has a negative impact on health outcomes? Would a uniform 'dress code' really be able to improve patient compliance in a considerable way? Read more

A successful MSL job search will require you to utilise an array of tools involving both passive and active strategies. While online job boards and networking remain popular methods of searching for new roles, social media can prove to be very valuable in your search. Read more

Pharma IQ provides you with a quick update of the activities of the Top 10 players in the Japanese pharmaceutical market in 2011. Read more